Uploaded January 2025 | Updated September 2026, 3 hours ago
Beth Pollack, Research Scientist at MIT, presents her research on Less Studied Comorbidities in Infection-Associated Chronic Illnesses. Her presentation includes newly discovered studies that are a world-first presented at our 2024 conference: Understanding EDS/HSD+ Symptomology, Diagnoses & Treatment - A Guide for Primary Care Practitioners & Physician Specialists.
Our mission at EDS Canada Foundation is to help individuals overcome the challenges of living with Ehlers-Danlos Syndromes and other chronic pain diseases through knowledge, sharing resources, awareness, education, peer support, and research to find cures. Learn more at theilcfoundation.org
Below you will find a brief summary of Beth Pollack's presentation:
Beth Pollack, a research scientist at MIT, focuses on the connections between long COVID, ME/CFS, and connective tissue disorders. Her work highlights how these illnesses share common symptoms, risk factors, and triggers.
Pollack emphasizes the high prevalence of hypermobility and connective tissue disorders in these conditions. Her research examines the impact of these illnesses on various organs, including the brain, spine, and reproductive system.
She discusses the role of infections, environmental exposures, and physical injuries as potential triggers. Particularly, she examines the potential link between SARS-CoV-2 infection and the development of long-term susceptibility to other infections.
Pollack also investigates sex differences, noting the disproportionate impact of these illnesses on women. She explores the potential role of testosterone levels and neutralizing antibody titers as possible explanations for this disparity.
She underscores the importance of understanding the prevalence and mechanisms of spinal conditions in these illnesses. Her research calls for a multidisciplinary approach, involving scientists, clinicians, and patients, to identify research priorities, develop screening tools, and advance clinical trials.
Pollack emphasizes the need for non-invasive treatments, high-resolution imaging, and multi-omic profiling to identify tissue-based biomarkers and understand the mechanisms of connective tissue damage. She also advocates for accessible and validated screening tools for spinal disorders, including potential low-risk assessments.
Furthermore, she highlights the need for comprehensive research on reproductive health challenges in these illnesses, including infertility, endometriosis, and adverse pregnancy complications. Her presentation calls for further investigation into the role of sex hormones, the menstrual cycle, the reproductive tract microbiome, and potential biomarkers associated with connective tissue disorders.
Finally, Pollack underscores the importance of addressing these understudied areas to improve understanding, diagnosis, and treatment of reproductive health conditions in individuals with infection-associated chronic illnesses.
Beth Pollack, Research Scientist at MIT, presents her research on Less Studied Comorbidities in Infection-Associated Chronic Illnesses. Her presentation includes newly discovered studies that are a world-first presented at our 2024 conference: Understanding EDS/HSD+ Symptomology, Diagnoses & Treatment - A Guide for Primary Care Practitioners & Physician Specialists.
Our mission at EDS Canada Foundation is to help individuals overcome the challenges of living with Ehlers-Danlos Syndromes and other chronic pain diseases through knowledge, sharing resources, awareness, education, peer support, and research to find cures. Learn more at theilcfoundation.org
Below you will find a brief summary of Beth Pollack's presentation:
Beth Pollack, a research scientist at MIT, focuses on the connections between long COVID, ME/CFS, and connective tissue disorders. Her work highlights how these illnesses share common symptoms, risk factors, and triggers.
Pollack emphasizes the high prevalence of hypermobility and connective tissue disorders in these conditions. Her research examines the impact of these illnesses on various organs, including the brain, spine, and reproductive system.
She discusses the role of infections, environmental exposures, and physical injuries as potential triggers. Particularly, she examines the potential link between SARS-CoV-2 infection and the development of long-term susceptibility to other infections.
Pollack also investigates sex differences, noting the disproportionate impact of these illnesses on women. She explores the potential role of testosterone levels and neutralizing antibody titers as possible explanations for this disparity.
She underscores the importance of understanding the prevalence and mechanisms of spinal conditions in these illnesses. Her research calls for a multidisciplinary approach, involving scientists, clinicians, and patients, to identify research priorities, develop screening tools, and advance clinical trials.
Pollack emphasizes the need for non-invasive treatments, high-resolution imaging, and multi-omic profiling to identify tissue-based biomarkers and understand the mechanisms of connective tissue damage. She also advocates for accessible and validated screening tools for spinal disorders, including potential low-risk assessments.
Furthermore, she highlights the need for comprehensive research on reproductive health challenges in these illnesses, including infertility, endometriosis, and adverse pregnancy complications. Her presentation calls for further investigation into the role of sex hormones, the menstrual cycle, the reproductive tract microbiome, and potential biomarkers associated with connective tissue disorders.
Finally, Pollack underscores the importance of addressing these understudied areas to improve understanding, diagnosis, and treatment of reproductive health conditions in individuals with infection-associated chronic illnesses.
